Is your product secure from the “bad guys”? Probably not…
Pharmaceutical Executive editor Fred Gebhart moderates the third of three episodes in our podcast series on a topic that is critical to the pharmaceutical business: how to reduce the safety and financial risks associated with product diversion and counterfeiting.
Episode One defined the problem of product security, and explained the risks. Episodes Two and Three discuss defenses that pharma companies can consider, as well as both the challenges and opportunities presented when implementing these defenses.
Fred is joined by two experts in this field, Ron Guido and Kent Mansfield. Ron is an independent consultant specializing in the field of brand protection, and he is the former Vice President of Global Brand Protection and Supply Chain Integrity for Johnson and Johnson. Kent is the President of TruTag Technologies, Inc., a leading product authentication solutions company. He has worked as an executive for leading private and public technology companies in the brand protection and technology markets.
Click the blue box below to access this twelve-minute podcast. You’ll hear a thought provoking discussion of the how to implement effective safeguards against products being compromised in the supply chain. (You can hear Episode One and Two at http://www.pharmexec.com/how-dose-technologies-mitigate-safety-risks-and-reduce-product-diversion-and-counterfeiting-0) |
